Market Indices
Sector Heatmap
SGMT — Sagimet Biosciences Inc. Series A Common Stock
NasdaqSagimet Biosciences Inc. Series A Common Stock
- O
- 8.80
- H
- 8.94
- L
- 8.63
- V
- 1.23M
SGMT — Latest News & Headlines
20 StoriesAbout $115 million from a share sale is expected to help fund Sagimet's acne trial and other drug work. - Stock Titan
About $115 million from a share sale is expected to help fund Sagimet's acne trial and other drug work. Stock Titan
Sagimet Biosciences (SGMT): Phase 3 Trial, FDA Path and Cash Runway Set Up Key Catalysts - Yahoo Finance
Sagimet Biosciences (SGMT): Phase 3 Trial, FDA Path and Cash Runway Set Up Key Catalysts Yahoo Finance
Sagimet Biosciences (NasdaqGM:SGMT) Stock Forecast & Analyst Predictions - Simply Wall Street
Sagimet Biosciences (NasdaqGM:SGMT) Stock Forecast & Analyst Predictions Simply Wall Street
Why Is SGMT Stock Surging Premarket Today? - Stocktwits
Why Is SGMT Stock Surging Premarket Today? Stocktwits
(SGMT) and the Role of Price-Sensitive Allocations - Stock Traders Daily
(SGMT) and the Role of Price-Sensitive Allocations Stock Traders Daily
Why Is Sagimet Biosciences Stock Trading Higher Today? - Sagimet Biosciences (NASDAQ:SGMT) - Benzinga
Why Is Sagimet Biosciences Stock Trading Higher Today? - Sagimet Biosciences (NASDAQ:SGMT) Benzinga
Sagimet closes down after acne drug denifanstat data, closing of stock offering - Seeking Alpha
Sagimet closes down after acne drug denifanstat data, closing of stock offering Seeking Alpha
Sagimet stock surges on positive acne trial data - Investing.com
Sagimet stock surges on positive acne trial data Investing.com
Sagimet raised about $115 million, with an acne drug trial among its planned uses. - Stock Titan
Sagimet raised about $115 million, with an acne drug trial among its planned uses. Stock Titan
Sagimet Raises $115M At Premium To Fund Phase 3 Acne Drug Trial – SGMT Stock Surges Pre-Market - Yahoo Finance
Sagimet Raises $115M At Premium To Fund Phase 3 Acne Drug Trial – SGMT Stock Surges Pre-Market Yahoo Finance
Behavioral Patterns of SGMT and Institutional Flows - Stock Traders Daily
Behavioral Patterns of SGMT and Institutional Flows Stock Traders Daily
Cantor Fitzgerald reiterates Sagimet stock rating on acne trial data By Investing.com - Investing.com Nigeria
Cantor Fitzgerald reiterates Sagimet stock rating on acne trial data By Investing.com Investing.com Nigeria
Stock sales through Leerink are suspended at Sagimet Biosciences (SGMT). - Stock Titan
Stock sales through Leerink are suspended at Sagimet Biosciences (SGMT). Stock Titan
Sagimet Prices $115 Million Offering of Series A Shares, Warrants; Shares Rise Pre-Bell - Yahoo Finance
Sagimet Prices $115 Million Offering of Series A Shares, Warrants; Shares Rise Pre-Bell Yahoo Finance
Warrants carry a 9.99% ownership cap in a passive Sagimet Biosciences (SGMT) stake. - Stock Titan
Warrants carry a 9.99% ownership cap in a passive Sagimet Biosciences (SGMT) stake. Stock Titan
Sagimet Biosciences Highlights 52-Week Acne Data, Sets U.S. Phase III Trial Launch - Yahoo Finance
Sagimet Biosciences Highlights 52-Week Acne Data, Sets U.S. Phase III Trial Launch Yahoo Finance
SGMT Oct 2027 10.000 call (SGMT271015C00010000) Stock Price, News, Quote & History - Yahoo! Finance Canada
SGMT Oct 2027 10.000 call (SGMT271015C00010000) Stock Price, News, Quote & History Yahoo! Finance Canada
SGMT Dec 2026 10.000 call (SGMT261218C00010000) Stock Price, News, Quote & History - Yahoo! Finance Canada
SGMT Dec 2026 10.000 call (SGMT261218C00010000) Stock Price, News, Quote & History Yahoo! Finance Canada
Sagimet Biosciences Closes Offering of Shares, Warrants - Yahoo Finance
Sagimet Biosciences Closes Offering of Shares, Warrants Yahoo Finance
Citizens cuts Sagimet Biosciences stock price target on trial data - Investing.com
Citizens cuts Sagimet Biosciences stock price target on trial data Investing.com